PepDiana
Back to Evidence
Primary experimental recordNegative / threshold

PMC13138602::ACT044644

Phoenixin-14 amide

Evidence text

Paper-level observation

Table 1: FSH (IU/L) PNX 2.5 group 7.54 ± 0.83. Text: While FSH levels showed a trend toward recovery in PNX-14-treated groups (ranging from 7.54 ± 0.83 to 9.24 ± 0.72 IU/L), these increases were not statistically significant.
tableConfidence: medium

Assay observation

Activity
Metabolic/Cardiovascular
Subtype
Other
Measure
other
Comparator
=
Raw observation
7.54 ± 0.83 other
Normalized measurement
=7.54 other
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Rattus norvegicus
Assay method
Not reported by source
Sequence
DVQPPGLKVWSDPFNH
Standardization
ready simple

Source publication

Phoenixin-14 ameliorates ovarian morphology in a DHEA-induced rat model of PCOS

Reproduction & Fertility · 2026

DOI 10.1530/RAF-25-0142 PMC13138602
Parent mention

Related peptide identities

PEPDIA-PLP-000501

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.